Singular Genomics Systems Inc

NASDAQ: OMIC    
Share price (6/17/24): $0.34    
Market cap (6/17/24): $25.2 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.10
from 10-Q 4 pages First Amendment to Agreement for Termination of Lease This First Amendment to Agreement for Termination of Lease (This “First Amendment”) Is Made as of August 31, 2023, by and Between Are-10933 North Torrey Pines, LLC, a Delaware Limited Liability Company (“Landlord”), and Singular Genomics Systems, Inc., a Delaware Corporation (“Tenant”)
12/34/56
EX-10.9
from 10-Q 5 pages Agreement for Termination of Lease
12/34/56
EX-10.8
from 10-Q 10 pages Sixth Amendment to Lease
12/34/56
EX-10.7
from 10-Q 5 pages Fifth Amendment to Lease
12/34/56
EX-10.6
from 10-Q 10 pages Fourth Amendment to Lease
12/34/56
EX-10.5
from 10-Q 6 pages Third Amendment to Lease
12/34/56
EX-10.4
from 10-Q 4 pages Second Amendment to Lease
12/34/56
EX-10.3
from 10-Q 4 pages First Amendment to Lease
12/34/56
EX-10.2
from 10-Q 33 pages Lease Agreement
12/34/56
EX-10.1
from 10-Q 8 pages Second Amendment to Lease Agreement This Second Amendment to Lease Agreement (This “Second Amendment”) Is Made This Recitals
12/34/56
EX-10
from 10-K 9 pages Singular Genomics Systems, Inc. February 28, 2023
12/34/56
EX-10.1
from 8-K 29 pages Singular Genomics Systems, Inc. 2021 Equity Incentive Plan (As Amended and Restated on July 22, 2022) Singular Genomics Systems, Inc. 2021 Equity Incentive Plan
12/34/56
EX-10.1
from 10-Q 65 pages Lease Agreement
12/34/56
EX-10.1
from 8-K 23 pages Exchange Agreement
12/34/56
EX-10.14
from S-1/A 12 pages Singular Genomics Systems, Inc. Executive Severance Plan
12/34/56
EX-10.13
from S-1/A 8 pages Singular Genomics Systems, Inc. Management Cash Incentive Plan
12/34/56
EX-10.4
from S-1/A 15 pages Singular Genomics Systems, Inc. 2021 Employee Stock Purchase Plan (As Adopted on May 19, 2021) Singular Genomics Systems, Inc. 2021 Employee Stock Purchase Plan
12/34/56
EX-10.3
from S-1/A 29 pages Singular Genomics Systems, Inc. 2021 Equity Incentive Plan (As Adopted on May 19, 2021) Singular Genomics Systems, Inc. 2021 Equity Incentive Plan
12/34/56
EX-10.1
from S-1/A 11 pages [Amended and Restated]1 Indemnity Agreement
12/34/56
EX-10.12
from S-1 45 pages Certain Identified Information Has Been Omitted From This Document Because It Is Both Not Material and Would Likely Cause Competitive Harm to the Registrant if Publicly Disclosed, and Has Been Marked “[***]” to Indicate Where Omissions Have Been Made. Exclusive License Agreement
12/34/56